Clinical Trial: Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890351) titled 'Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids' on March 20.

Brief Summary: This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

Study Start Date: April 10

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: Tozorakimab

The drug will be administered subcutaneously.

DRUG: Placebo

Placebo will be admin...